• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:于丽燕,孙荣梅,冉桂梅,相秉仁.米屈肼胶囊在中国健康受试者中药代动力学的研究[J].药学研究,2017,36(6):337-340[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 4372次   下载 3037次 本文二维码信息
码上扫一扫!
米屈肼胶囊在中国健康受试者中药代动力学的研究
于丽燕,孙荣梅,冉桂梅,相秉仁
字体:加大+|默认|缩小-
(中国药科大学工学院,江苏 南京 211198)
摘要:
目的 研究米屈肼胶囊在健康受试者中单次给药、多次给药的药代动力学规律。方法 采用多剂量单序列给药设计方案。12名健康受试者分别按体重由重到轻排序编号,男前女后。统一先服用低剂量250 mg(250 mg/粒×1);经清洗期后服用高剂量1 000 mg(500 mg/粒×2);再经清洗期后服用中剂量500 mg(500 mg/粒×1),并在中剂量下进行连续给药(连续给药6 d,第1~5天每日2次,第6天早上1次,每次500 mg)。结果 结果表明在250~1 000 mg剂量范围内,米屈肼呈非线性动力学特征。半衰期随着剂量增加而延长,因此多次服药后在人体内具有明显的蓄积作用。结论 本方法适合于米屈肼的人体药代动力学研究。
关键词:  米屈肼  高效液相色谱-质谱  血药浓度  药动学
DOI:10.13506/j.cnki.jpr.2017.06.008
基金项目:
Pharmacokinetic research of oral Mildronate Capsule in healthy Chinese subjects
YU Liyan,SUN Rongmei,RAN Guimei,XIANG Bingren
(Engineering Institute,China Pharmaceutical university,Nanjing 211198,China)
Abstract:
Objective To study the pharmacokinetics of mildronate capsules in healthy subjects in a single and multiple dose.Methods Using multi-dose of single-sequence for drug design,12 healthy subjects were respectively numbered according to the weight from heavy to light order number,all the female volunteers were behind the male volunteers.All the volunteers were given the low doses of 250 mg (250 mg/pill×1) medicine;After cleaning period all the volunteers were given the high doses of 1 000 mg (500 mg/pill×2) medicine;Again after cleaning period all the volunteers were given the dose 500 mg (500 mg/pill×1) medicine,and then all the volunteers were given the middle-dose of this medicine(oral drug 6 days in a row,oral this medicine twice a day from the first day to the fifth day,oral the medicine once time in the morning of the sixth day,Every time the dose is 500 mg).Results The pharmacokinetic characteristics of mildronate were nolinear pharmacokinrtics in human body.The t1/2 was prolonged with increasing does,the result of multiple dose indicated the occurrence of accumulation in the multidoses.Conclusion The method developed in this study was suitable for the pharmacokinetic study of mildronate.
Key words:  Mildronate  HPLC-MS/MS  Plasma concentration  Pharmacokinetics
今日访问量:2643    总访问量:55339157
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司